in Newswire March 5, 2021

Jailed ‘Pharma Bro’ Martin Shkreli Facing Antitrust Class Action Linked to ‘Astronomical’ Daraprim Price Increase

by Corrado Rizzi

Last Updated on March 5, 2021

BCBSM, Inc. v. Vyera Pharmaceuticals, LLC et al.

Filed: March 4, 2021 § 1:21-cv-01884

"Pharma bro" Martin Shkreli and his former companies face an antitrust class action over their alleged manipulation of the price of Daraprim.

Last Updated on March 5, 2021 — 5:03 PM

Corrado Rizzi

corrado@classaction.org

Corrado Rizzi is the Managing Editor and a writer for ClassAction.org.

About ClassAction.org

ClassAction.org is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.